Regal Beloit Corporation

RBC 4 | $244.89 -0.42% 0.0% 160K

(0.0% 1d) (-7.8% 1m) (13.9% 1y) (0.0% 2d) (-0.4% 3d) (0.0% 7d) (-25.17% volume)
Earnings Calendar: 2024-02-08
Market Cap: $ 6,901,470,634
http://www.regalbeloit.com
Sec Filling | Patents | 19560 employees

Regal Beloit Corp. engages in the manufacture of electric motors, electrical motion controls, power generation, and power transmission products. It operates through the following segments: Commercial and Industrial Systems, Climate Solutions and Power Transmission Solutions. The Commercial and Industrial Systems produces medium and large motors, commercial and industrial equipment, generator, and custom drives and systems. The Climate Solutions segment offers small motors, controls, and air moving solutions serving markets including residential and light commercial HVAC, water heaters and commercial refrigeration. The Power Transmission Solutions segment manufactures, sells, and services belt and chain drives, helical and worm gearing, mounted and unmounted bearings, couplings, modular plastic belts, conveying chains and components, hydraulic pump drives, large open gearing, and specialty mechanical products serving markets including beverage, bulk handling, metals, special machinery, energy, aerospace, and general industrial. The company was founded in 1955 and is headquartered in Beloit, WI.

energy renal refrigerants refrigerant bhvac eletrical

add to watch list Paper trade email alert is off

Calliditas Therapeutics AB

CALT | $18.5 1.65% 1.62% 1K

Health Technology

(0.0% 1d) (-15.3% 1m) (-24.1% 1y) (0.0% 2d) (1.6% 3d) (-1.1% 7d) (-22.85% volume)
Earnings Calendar:
Market Cap: $ 551,115,814
http://www.calliditas.se
Sec Filling | Patents | 16 employees

Calliditas Therapeutics AB provides pharmaceutical products for patients with niche indications. It focuses on development and commercialization of the product candidate Nefecon intended for treatment of patients with the inflammatory renal disease IgA nephropathy. The company was founded by Mikael Bender and Bengt Åke Julander on February 20, 2004 and is headquartered in Stockholm, Sweden.

renal nephropathy treatment iga nephropathy

add to watch list Paper trade email alert is off

Nephros, Inc.

NEPH | $2.19 2.34% 2.28% 7.3K

Health Technology

(0.0% 1d) (-0.9% 1m) (51.1% 1y) (0.0% 2d) (2.3% 3d) (4.3% 7d) (488.89% volume)
Earnings Calendar: 2024-03-13
Market Cap: $ 23,091,664
http://www.nephros.com
Sec Filling | Patents | 25 employees

Nephros, Inc. is a medical device company, which engages in developing and selling liquid purification filters and an on-line mid dilution hemodiafiltration system. The company operates in two segments: Water Filtration and Renal Products. The Water Filtration segment includes both the medical device and commercial filtration product lines. The Renal Products segment comprises of SRP, which is focused on the development of medical device products for patients with renal disease, including a second-generation HDF system for the treatment of patients with ESRD. Its ultrafilters are used in dialysis centers for the removal of biological contaminants from water, bicarbonate concentrate and blood. The company was founded on April 3, 1997 and is headquartered in South Orange, NJ.

renal treatment

add to watch list Paper trade email alert is off

Medtronic plc

MDT | $80.38 -1.12% -0.03% 5M

Health Technology

(0.0% 1d) (-4.0% 1m) (-10.7% 1y) (0.0% 2d) (-1.1% 3d) (1.1% 7d) (-5.05% volume)
Earnings Calendar: 2024-02-20
Market Cap: $ 106,730,375,685
http://www.medtronic.com
Sec Filling | Patents | 90000 employees

(US) Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiac and Vascular Group; Minimally Invasive Technologies Group; Restorative Therapies Group; and Diabetes Group. The Cardiac and Vascular Group segment consist Cardiac Rhythm and Heart Failure, Coronary and Structural Heart, and Aortic and Peripheral Vascular divisions. The Minimally Invasive Technologies Group segment comprises Surgical Innovations and Respiratory, Gastrointestinal, and Renal divisions. The Restorative Therapies Group contains Spine, Brain, Specialty Therapies, and Pain Therapies divisions. The Diabetes Group segment focuses in the development, manufacturing, and marketing of products and services for the management of Type I and Type II diabetes. The company was founded in 1949 and is headquartered in Dublin, Ireland.

respiratory heart gastrointestinal diabetes diabetic renal

add to watch list Paper trade email alert is off

Regulus Therapeutics Inc.

RGLS | $2.22 -1.77% -1.35% 92K

Health Technology

(0.0% 1d) (-22.0% 1m) (64.4% 1y) (0.0% 2d) (-1.8% 3d) (4.2% 7d) (-9.63% volume)
Earnings Calendar: 2024-03-21
Market Cap: $ 145,332,857
http://www.regulusrx.com
Sec Filling | Patents | 21 employees

(US) Regulus Therapeutics, Inc. is a biopharmaceutical company, which engages in the discovery and development of drugs targeting microRNAs. Its two lead product candidates, RG-012 and RGLS4326, are in clinical development. RG-012 is an anti-miR targeting miR-21 in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease. RGLS4326 is an anti-miR targeting miR-17 in Phase I clinical trial for the treatment of autosomal dominant polycystic kidney disease. The firm is also developing a pipeline of preclinical drug product candidates in renal, hepatic, and central nervous systems diseases. The company was founded in September 2007 and is headquartered in San Diego, CA.

autonomous kidney diseases renal hepatitis antiviral nervous system clinical trials treatment kidney

add to watch list Paper trade email alert is off

DaVita Inc.

DVA | News | $132.74 -0.87% 0.0% 470K

Health Services

(0.0% 1d) (-1.9% 1m) (53.9% 1y) (0.0% 2d) (-0.9% 3d) (3.8% 7d) (17.62% volume)
Earnings Calendar: 2024-02-13
Market Cap: $ 11,641,298,000
http://www.davita.com
Sec Filling | Patents | 65000 employees

(US) DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services; and Other-Ancillary Services and Strategic Initiatives. The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

renal kidney

add to watch list Paper trade email alert is off

Akebia Therapeutics, Inc.

AKBA | $1.37 -0.74% 1.5M

Health Technology

(0.0% 1d) (-31.5% 1m) (72.8% 1y) (0.0% 2d) (0.0% 3d) (0.7% 7d) (Infinity% volume)
Earnings Calendar: 2024-03-07
Market Cap: $ 286,840,017
http://www.akebia.com
Sec Filling | Patents | 360 employees

(US) Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney disease. The firm also involves in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.

kidney diseases renal metabolic treatment rice kidney

add to watch list Paper trade email alert is off

Baxter International Inc.

BAX | $40.93 -0.22% 0.0% 2.2M

Health Technology

(0.0% 1d) (-1.5% 1m) (-11.2% 1y) (0.0% 2d) (-0.2% 3d) (3.7% 7d) (-18.3% volume)
Earnings Calendar: 2024-02-08
Market Cap: $ 20,785,376,996
http://www.baxter.com
Sec Filling | Patents | 50000 employees

(US) Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

nutrition renal aesthetic injection

add to watch list Paper trade email alert is off

Astrazeneca PLC

AZN | News | $71.2 0.49% 0.46% 5.4M

Health Technology

(0.0% 1d) (7.3% 1m) (-3.3% 1y) (0.0% 2d) (1.1% 3d) (3.9% 7d) (Infinity% volume)
Earnings Calendar:
Market Cap: $ 220,751,511,411
http://astrazeneca.com
Sec Filling | Patents | 70600 employees

AstraZeneca Plc is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

cardiovascular respiratory urea renal metabolic

add to watch list Paper trade email alert is off

Regal Rexnord Corp

RRX | News | $164.23 -1.54% 0.0% 380K

Manufacturing

(0.0% 1d) (-8.5% 1m) (30.2% 1y) (0.0% 2d) (-1.5% 3d) (2.8% 7d) (-4.82% volume)
Earnings Calendar: 2024-02-07
Market Cap: $ 10,908,914,850
https://www.regalbeloit.com
Sec Filling | Patents | 2021 employees

(US) Regal Beloit Corporation is a global leader in the engineering and manufacturing of electric motors and controls, power generation solutions, and power transmission products serving customers throughout the world. Regal creates a better tomorrow by developing and responsibly producing energy-efficient products and systems. The company is comprised of four operating segments: Commercial Systems, Industrial Systems, Climate Solutions, and Power Transmission Solutions. Regal is headquartered in Beloit, Wisconsin and has manufacturing, sales and service facilities worldwide.

energy eletrical

add to watch list Paper trade email alert is off